印度今年的目标是生产结核病药物Rifampicin,促进其自力更生和经济。 India aims to produce TB drug Rifampicin this year, boosting its self-reliance and economy.

印度计划在今年开始生产一种主要的肺结核治疗药物Rifampicin, 目的是消灭肺结核。 India plans to start producing Rifampicin, a key TB treatment drug, this year, aiming to eliminate TB. 该国还预期生产其他基本药物,如Prednisolone、Betamethasone和Dexamethasone。 The country also expects to produce other essential drugs like Prednisolone, Betamethasone, and Dexamethasone. 目前,印度进口Rifampicin,但政府的散装药品生产相关奖励计划(PLI)力求实现自力更生和减少对进口的依赖,促进国内经济。 Currently, India imports Rifampicin, but the government's Production Linked Incentive (PLI) scheme for Bulk Drugs seeks to achieve self-reliance and reduce import dependence, boosting the domestic economy.